Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Testosterone therapy linked to CV risk in men with HIV

Key clinical point: Men with HIV are likely prone to the same cardiovascular risks from testosterone therapy as other men.

Major finding: The risk of significant coronary artery calcium progression was 2.0 times greater among continuous users and 2.4 times greater among new users, compared with former users.

Study details: A review of 300 men who have sex with men

Disclosures: The work was funded by the National Institutes of Health. The lead investigator didn't report any disclosures.


Haberlen S et al. CROI 2020, Abstract 662.